norfluoxetine has been researched along with Kidney Diseases in 2 studies
norfluoxetine: metabolite of fluoxetine; RN given refers to parent cpd without isomeric designation
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Blood samples for the measurement of fluoxetine and its active metabolite norfluoxetine were drawn 13 times in the first 48 hr after dosing and thrice weekly thereafter for 4 wk." | 1.27 | Fluoxetine kinetics and protein binding in normal and impaired renal function. ( Aronoff, GR; Bergstrom, RF; Lemberger, L; Pottratz, ST; Sloan, RS; Wolen, RL, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aronoff, GR | 1 |
| Bergstrom, RF | 2 |
| Pottratz, ST | 1 |
| Sloan, RS | 1 |
| Wolen, RL | 1 |
| Lemberger, L | 2 |
| Beasley, CM | 1 |
| Levy, NB | 1 |
| Blumenfield, M | 1 |
1 review available for norfluoxetine and Kidney Diseases
| Article | Year |
|---|---|
The effects of renal and hepatic disease on the pharmacokinetics, renal tolerance, and risk-benefit profile of fluoxetine.
Topics: Adult; Aged; Clinical Trials as Topic; Depressive Disorder; Dose-Response Relationship, Drug; Drug A | 1993 |
1 other study available for norfluoxetine and Kidney Diseases
| Article | Year |
|---|---|
Fluoxetine kinetics and protein binding in normal and impaired renal function.
Topics: Administration, Oral; Blood Proteins; Fluoxetine; Half-Life; Humans; Kidney Diseases; Kinetics; Male | 1984 |